Revenue ($USD) : $6,618,266,241
Revenue (foreign currencies) : JP¥870,030,000,000
R&D spend : $509,649,784.00
Employees : 22,756
Fiscal year end : 03/31/23
CEO : Stefan Kaufmann, president and CEO; Gabriela Kaynor, therapeutic solutions global division head; Frank Drewalowski, endoscopic solutions global division head; Richard Reynolds, president, Medical Systems Group, Olympus Corporation of the Americas

Olympus faced a challenge in March 2023 after the FDA sent it a warning letter over its endoscope and endoscope accessories plant in Tokyo. The company also received two separate letters at the end of 2022.

On the positive side, Olympus planned to establish a series of digital excellence centers following its acquisition of London-based Odin Vision and its cloud AI-enabled applications for endoscopy. Olympus also recently launched its next-gen EasySuite ES-IP system for procedure room visualization and integration in the U.S.

Olympus medical devices primarily serve gastroenterology, general surgery, pulmonology, bronchoscopy, urology, gynecology, otolaryngology, bariatrics, orthopedics and anesthesiology. –CN